Daniel G. Wright - Concepedia

Author

Daniel G. Wright

Also Known As

D G Wright, D Wright, D. G. WRIGHT, D. G. Wright, D. Wright, D.G. Wright, D.G.D. Wright, DANIEL G. WRIGHT, Daniel G Wright, Daniel G. Wright

127

Publications

6.7K

Citations

H-Index

136

Concepts

All Affiliations

Boston University Walter Reed Army Institute of Research Boston Medical Center National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Daniel G. Wright is an author at Boston University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	43	3.5K
2	Health Sciences	7	7	311
3	Engineering	3	3	312
4	Natural Sciences	2	2	52
5	Public Health	1	1	49

Daniel G. Wright

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study Martha Skinner, Vaishali Sanchorawala, David C. Seldin, Annals of Internal Medicine	2004	614
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. John M. Harlan, Paul D. Killen, L A Harker, Journal of Clinical Investigation Normal NeutrophilsImmunologyPathologyEndothelial Cell SurfaceCellular Physiology	1981	436
Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients Raymond L. Comenzo, Evan Vosburgh, Rodney H. Falk, Blood	1998	342
Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte Transfusions Daniel G. Wright, Kathleen J. Robichaud, Philip A. Pizzo, New England Journal of Medicine	1981	287
Secretory Responses of Human Neutrophils: Exocytosis of Specific (Secondary) Granules by Human Neutrophils during Adherence <i>in vitro</i> and during Exudation <i>in vivo</i> Daniel G. Wright, John I. Gallin The Journal of Immunology EngineeringCell AdhesionImmunologyGlycobiologyBlood Cell	1979	285
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial Vaishali Sanchorawala, Daniel G. Wright, Michael Rosenzweig, Blood	2006	258
Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy Élie Choufani, Vaishali Sanchorawala, Timothy J. Ernst, Blood	2001	228
Role of secretory events in modulating human neutrophil chemotaxis. John I. Gallin, Daniel G. Wright, E Schiffmann Journal of Clinical Investigation Cell AdhesionInnate Immune SystemImmunologyCytoskeletonInnate Immunity	1978	191
Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients Daniel G. Wright, David C. Dale, Anthony S. Fauci, Medicine UrologyAutoimmune DiseaseHuman Cyclic NeutropeniaGranulocyteImmunodeficiencies	1981	168
Tolerability and Efficacy of Thalidomide for the Treatment of Patients with Light Chain–Associated (AL) Amyloidosis David C. Seldin, Élie Choufani, Laura M. Dember, Clinical Lymphoma MedicinePharmacologyLight Chain–associatedNeuropathology	2003	146

Page 1